LAHORE: The Pharma Bureau representatives have expressed reservations over the new drug pricing policy proposed by the Policy Board of the Drug Regulatory Authority of Pakistan (DRAP).
The DRAP had proposed 30 per cent cut on the life-saving and other drugs.
The Pharma Bureau, which is research-based multinational pharmaceutical companies, urged the government, Finance Minister Senator Ishaq Dar and State Minister Saira Afzal Tarar to avert a potential drug crisis by formulating a committee to review the draft drug pricing policy.
On the other hand, Pakistan Young Pharmacists Association welcomed the DRAP’s decision saying that it would help improve health status of the patients.
Askari General Insurance, Askari Life transfer 51% stakes from Army Welfare Trust to Fauji Foundation
KARACHI: Askari General Insurance Co. Ltd. and Askari Life Assurance Company Limited have disclosed the transfer of their respective 51%...
